Q4 2019

Filed May 1, 2020 · 10-K · 122 days after period end · 0001654954-20-004731

Q4 2019 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$10.56K

derivedno prior Q4 2018 on file

Net Income

-$396.62K

derivedN/M vs Q4 2018

EPS, diluted—

Same quarter

Metric	Q4 2019derived from reported figures	Q4 2018derived from reported figures	Q4 2017derived from reported figures	Q4 2016derived from reported figures
Revenue	$10.56K	—	$0.00	$0.00
Net Income	-$396.62K	-$338.66K	-$211.48K	-$1.12M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR